X T L Biopharmaceuticals reported $1.3K in Interest Expense on Debt for its fiscal quarter ending in June of 2024.





Interest Expense On Debt Change Date
Alaunos Therapeutics USD 0 0 Dec/2023
Bioline Rx USD 360K 84K Sep/2025
Teva Pharmaceutical Industries USD 220M 17M Dec/2025